ISSN: 1381-6128

Journal Home

Journal Guideline

Current Pharmaceutical Design Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Pharmaceutical Design is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 166. It has an SJR impact factor of 0.571 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.571.

Current Pharmaceutical Design focuses its scope in these topics and keywords: systematic, current, erectile, ellagic, essential, fatty, future, impact, inhibitors, inhibitorsphosphodiesterase, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q2) Pharmacology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0.571

SJR Impact factor

166

H Index

434

Total Docs (Last Year)

1532

Total Docs (3 years)

41393

Total Refs

4939

Total Cites (3 years)

1411

Citable Docs (3 years)

2.94

Cites/Doc (2 years)

95.38

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Computer-Aided Molecular Design Q2
Current Cancer Drug Targets Q2
Journal of Pharmaceutical and Biomedical Analysis Q2
Current Drug Targets Q2
Current Topics in Medicinal Chemistry Q2

Compare this journals

Aims and Scope

Best articles by citations

Copper and Neurotoxicity in Autism Spectrum Disorder

microRNAs in Autism Spectrum Disorders

Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target

Endothelial Chemokines in Autoimmune Disease

New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives

Vitex Diterpenoids: Structural Diversity and Pharmacological Activity

Current Options for the Pharmacotherapy of Obesity

Current Trends in Vascular Biology and Atherothrombosis

Diabetes and Vascular Disease: Is It All About Glycemia?

The Effects of Quercetin Supplementation on Blood Pressures and Endothelial Function Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers

Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases

SHOW MORE ARTICLES

Potential of Gentiana lutea for the Treatment of Obesity-associated Diseases

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases

Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component

Effects of IGF-1 on the Cardiovascular System

Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review

Basic Cell Biology of Trypanosoma cruzi

The Plastid-Like Organelle of Apicomplexan Parasites as Drug Target

Adjunctive Immunotherapy of Mycobacterial Infections

Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS

Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations

Role of Dietary Fiber and Short-Chain Fatty Acids in the Colon